Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Argus Health
Healthtrust
Accenture
Merck
Citi
Boehringer Ingelheim
Johnson and Johnson
Chinese Patent Office
US Department of Justice
AstraZeneca

Generated: February 25, 2018

DrugPatentWatch Database Preview

Estrogens, conjugated synthetic b - Generic Drug Details

« Back to Dashboard

What are the generic sources for estrogens, conjugated synthetic b and what is the scope of estrogens, conjugated synthetic b freedom to operate?

Estrogens, conjugated synthetic b
is the generic ingredient in one branded drug marketed by Teva Branded Pharm and is included in one NDA. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Estrogens, conjugated synthetic b has seventeen patent family members in nine countries.

There are three drug master file entries for estrogens, conjugated synthetic b. One supplier is listed for this compound.
Summary for estrogens, conjugated synthetic b

US Patents and Regulatory Information for estrogens, conjugated synthetic b

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Branded Pharm ENJUVIA estrogens, conjugated synthetic b TABLET;ORAL 021443-003 May 10, 2004 DISCN No No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Teva Branded Pharm ENJUVIA estrogens, conjugated synthetic b TABLET;ORAL 021443-005 Apr 27, 2007 DISCN No No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Teva Branded Pharm ENJUVIA estrogens, conjugated synthetic b TABLET;ORAL 021443-001 Dec 20, 2004 DISCN No No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Teva Branded Pharm ENJUVIA estrogens, conjugated synthetic b TABLET;ORAL 021443-003 May 10, 2004 DISCN No No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Teva Branded Pharm ENJUVIA estrogens, conjugated synthetic b TABLET;ORAL 021443-005 Apr 27, 2007 DISCN No No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Teva Branded Pharm ENJUVIA estrogens, conjugated synthetic b TABLET;ORAL 021443-004 May 10, 2004 DISCN No No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Teva Branded Pharm ENJUVIA estrogens, conjugated synthetic b TABLET;ORAL 021443-002 Dec 20, 2004 DISCN No No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Teva Branded Pharm ENJUVIA estrogens, conjugated synthetic b TABLET;ORAL 021443-002 Dec 20, 2004 DISCN No No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Teva Branded Pharm ENJUVIA estrogens, conjugated synthetic b TABLET;ORAL 021443-004 May 10, 2004 DISCN No No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Teva Branded Pharm ENJUVIA estrogens, conjugated synthetic b TABLET;ORAL 021443-001 Dec 20, 2004 DISCN No No ➤ Sign Up ➤ Sign Up Y Y ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for estrogens, conjugated synthetic b

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
6,250,127 Heat-dissipating aluminum silicon carbide composite manufacturing method ➤ Sign Up
7,459,445 Estrogenic compounds and topical pharmaceutical formulations of the same ➤ Sign Up
7,749,989 Estrogenic compounds, methods of using and methods of administering the same ➤ Sign Up
8,227,454 Estrogenic compounds, pharmaceutical compositions and formulations comprising the same ➤ Sign Up
7,989,436 Estrogenic compounds and pharmaceutical formulations comprising the same ➤ Sign Up
6,844,334 (3) and (6) substitued estrogenic compounds ➤ Sign Up
7,179,799 (3) and (6) substituted estrogenic compounds ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for estrogens, conjugated synthetic b

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Accenture
Citi
Chubb
QuintilesIMS
Medtronic
Covington
Chinese Patent Office
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot